Literature DB >> 15537337

Piperidine-based nocaine/modafinil hybrid ligands as highly potent monoamine transporter inhibitors: efficient drug discovery by rational lead hybridization.

Jia Zhou1, Rong He, Kenneth M Johnson, Yanping Ye, Alan P Kozikowski.   

Abstract

Some piperidine-based nocaine/modafinil hybrid ligands have been designed, synthesized, and found to display an improved potency at all three monoamine transporters and particularly for DAT and/or NET. Some highly active and selective monoamine transporter inhibitors with low nanomolar to subnanomolar potency were identified. Ligands of this type may find important applications as positron emission tomography imaging tools and in the treatment of central nervous system disorders such as depression and sleep apnea.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15537337      PMCID: PMC1395211          DOI: 10.1021/jm040117o

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  17 in total

Review 1.  Treatment of mood disorders.

Authors:  Charles B Nemeroff; Michael J Owens
Journal:  Nat Neurosci       Date:  2002-11       Impact factor: 24.884

Review 2.  Cocaine, reward, movement and monoamine transporters.

Authors:  G R Uhl; F S Hall; I Sora
Journal:  Mol Psychiatry       Date:  2002       Impact factor: 15.992

Review 3.  The neurobiology of slow synaptic transmission.

Authors:  P Greengard
Journal:  Science       Date:  2001-11-02       Impact factor: 47.728

4.  Dopaminergic role in stimulant-induced wakefulness.

Authors:  J P Wisor; S Nishino; I Sora; G H Uhl; E Mignot; D M Edgar
Journal:  J Neurosci       Date:  2001-03-01       Impact factor: 6.167

Review 5.  The role of norepinephrine in the pathophysiology of cognitive disorders: potential applications to the treatment of cognitive dysfunction in schizophrenia and Alzheimer's disease.

Authors:  J I Friedman; D N Adler; K L Davis
Journal:  Biol Psychiatry       Date:  1999-11-01       Impact factor: 13.382

Review 6.  Monoamine transporter pharmacology and mutant mice.

Authors:  Raul R Gainetdinov; Tatyana D Sotnikova; Marc G Caron
Journal:  Trends Pharmacol Sci       Date:  2002-08       Impact factor: 14.819

7.  Increased dopaminergic transmission mediates the wake-promoting effects of CNS stimulants.

Authors:  S Nishino; J Mao; R Sampathkumaran; J Shelton
Journal:  Sleep Res Online       Date:  1998

8.  Reinforcing strength of a novel dopamine transporter ligand: pharmacodynamic and pharmacokinetic mechanisms.

Authors:  W L Woolverton; R Ranaldi; Z Wang; G A Ordway; I A Paul; P Petukhov; A Kozikowski
Journal:  J Pharmacol Exp Ther       Date:  2002-10       Impact factor: 4.030

9.  Mixed cocaine agonist/antagonist properties of (+)-methyl 4beta-(4-chlorophenyl)-1-methylpiperidine-3alpha-carboxylate, a piperidine-based analog of cocaine.

Authors:  Alan P Kozikowski; Kenneth M Johnson; Olivier Deschaux; Bidhan C Bandyopadhyay; Gian Luca Araldi; Gilberto Carmona; Patrik Munzar; Miles P Smith; Robert L Balster; Patrick M Beardsley; Srihari R Tella
Journal:  J Pharmacol Exp Ther       Date:  2003-04       Impact factor: 4.030

10.  SAR studies of piperidine-based analogues of cocaine. 4. Effect of N-modification and ester replacement.

Authors:  Pavel A Petukhov; Jianrong Zhang; Alan P Kozikowski; Cheng Z Wang; Yan Ping Ye; Kenneth M Johnson; Srihari R Tella
Journal:  J Med Chem       Date:  2002-07-18       Impact factor: 7.446

View more
  8 in total

Review 1.  Triple reuptake inhibitors as potential next-generation antidepressants: a new hope?

Authors:  Horrick Sharma; Soumava Santra; Aloke Dutta
Journal:  Future Med Chem       Date:  2015-11-30       Impact factor: 3.808

2.  Norepinephrine transporter inhibitors and their therapeutic potential.

Authors:  Jia Zhou
Journal:  Drugs Future       Date:  2004-12       Impact factor: 0.148

Review 3.  Evolutions in fragment-based drug design: the deconstruction-reconstruction approach.

Authors:  Haijun Chen; Xiaobin Zhou; Ailan Wang; Yunquan Zheng; Yu Gao; Jia Zhou
Journal:  Drug Discov Today       Date:  2014-09-27       Impact factor: 7.851

4.  The novel triple reuptake inhibitor JZAD-IV-22 exhibits an antidepressant pharmacological profile without locomotor stimulant or sensitization properties.

Authors:  Barbara J Caldarone; Neil E Paterson; Jia Zhou; Daniela Brunner; Alan P Kozikowski; Koen G C Westphal; Gerdien A H Korte-Bouws; Jolanda Prins; S Mechiel Korte; Berend Olivier; Afshin Ghavami
Journal:  J Pharmacol Exp Ther       Date:  2010-09-23       Impact factor: 4.030

5.  Convenient synthesis and biological evaluation of modafinil derivatives: benzhydrylsulfanyl and benzhydrylsulfinyl [1,2,3]triazol-4-yl-methyl esters.

Authors:  Jae-Chul Jung; Yeonju Lee; Jee-Young Son; Eunyoung Lim; Mankil Jung; Seikwan Oh
Journal:  Molecules       Date:  2011-12-15       Impact factor: 4.411

6.  Structure Modeling of the Norepinephrine Transporter.

Authors:  Izabella Góral; Kamil Łątka; Marek Bajda
Journal:  Biomolecules       Date:  2020-01-07

Review 7.  Chimeric Structures in Mental Illnesses-"Magic" Molecules Specified for Complex Disorders.

Authors:  Patrycja Kleczkowska
Journal:  Int J Mol Sci       Date:  2022-03-29       Impact factor: 5.923

8.  Simple synthesis of modafinil derivatives and their anti-inflammatory activity.

Authors:  Jae-Chul Jung; Yeonju Lee; Jee-Young Son; Eunyoung Lim; Mankil Jung; Seikwan Oh
Journal:  Molecules       Date:  2012-09-03       Impact factor: 4.411

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.